Medical - Healthcare Plans
Compare Stocks
4 / 10Stock Comparison
MOH vs UNH vs CVS vs CNC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
MOH vs UNH vs CVS vs CNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $10.01B | $330.28B | $102.56B | $26.15B |
| Revenue (TTM) | $45.08B | $449.71B | $402.07B | $198.10B |
| Net Income (TTM) | $188M | $12.04B | $1.77B | $-6.44B |
| Gross Margin | 9.6% | 18.8% | 13.8% | 14.9% |
| Operating Margin | 1.2% | 4.2% | 1.2% | -3.7% |
| Forward P/E | 38.3x | 19.9x | 11.3x | 16.4x |
| Total Debt | $3.95B | $78.39B | $93.59B | $18.78B |
| Cash & Equiv. | $4.25B | $24.36B | $8.51B | $17.89B |
MOH vs UNH vs CVS vs CNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Molina Healthcare, … (MOH) | 100 | 106.3 | +6.3% |
| UnitedHealth Group … (UNH) | 100 | 120.5 | +20.5% |
| CVS Health Corporat… (CVS) | 100 | 132.5 | +32.5% |
| Centene Corporation (CNC) | 100 | 83.5 | -16.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MOH vs UNH vs CVS vs CNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MOH lags the leaders in this set but could rank higher in a more targeted comparison.
UNH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
- 217.0% 10Y total return vs MOH's 323.6%
- Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting)
- 2.4% yield, 25-year raise streak, vs CVS's 3.3%, (2 stocks pay no dividend)
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.3%
- Beta 0.05, yield 3.3%, current ratio 0.84x
- Lower P/E (11.3x vs 19.9x)
- Beta 0.05 vs UNH's 0.59
CNC is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
- 19.4% revenue growth vs CVS's 7.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.4% revenue growth vs CVS's 7.8% | |
| Value | Lower P/E (11.3x vs 19.9x) | |
| Quality / Margins | Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.05 vs UNH's 0.59 | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +24.2% vs MOH's -39.9% | |
| Efficiency (ROA) | 3.9% ROA vs CNC's -7.9%, ROIC 9.2% vs -21.6% |
MOH vs UNH vs CVS vs CNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MOH vs UNH vs CVS vs CNC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UNH leads in 2 of 6 categories
CNC leads 1 • CVS leads 1 • MOH leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 10.0x MOH's $45.1B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to CNC's -3.3%. On growth, CVS holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $45.1B | $449.7B | $402.1B | $198.1B |
| EBITDAEarnings before interest/tax | $710M | $23.2B | $9.3B | -$5.9B |
| Net IncomeAfter-tax profit | $188M | $12.0B | $1.8B | -$6.4B |
| Free Cash FlowCash after capex | $251M | $19.7B | $7.8B | $6.3B |
| Gross MarginGross profit ÷ Revenue | +9.6% | +18.8% | +13.8% | +14.9% |
| Operating MarginEBIT ÷ Revenue | +1.2% | +4.2% | +1.2% | -3.7% |
| Net MarginNet income ÷ Revenue | +0.4% | +2.7% | +0.4% | -3.3% |
| FCF MarginFCF ÷ Revenue | +0.6% | +4.4% | +1.9% | +3.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.1% | +2.0% | +8.2% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.0% | +0.7% | +76.9% | +18.3% |
Valuation Metrics
CNC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 21.5x trailing earnings, MOH trades at a 63% valuation discount to CVS's 58.1x P/E. On an enterprise value basis, MOH's 10.0x EV/EBITDA is more attractive than UNH's 16.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $10.0B | $330.3B | $102.6B | $26.2B |
| Enterprise ValueMkt cap + debt − cash | $9.7B | $384.3B | $187.6B | $27.0B |
| Trailing P/EPrice ÷ TTM EPS | 21.54x | 27.50x | 58.05x | -3.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 38.29x | 19.87x | 11.27x | 16.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 9.95x | 16.48x | 12.52x | — |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 0.74x | 0.26x | 0.13x |
| Price / BookPrice ÷ Book value/share | 2.40x | 3.26x | 1.36x | 1.30x |
| Price / FCFMarket cap ÷ FCF | — | 20.55x | 13.14x | 6.05x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-29 for CNC. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs MOH's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.4% | +11.5% | +2.3% | -28.6% |
| ROA (TTM)Return on assets | +1.2% | +3.9% | +0.7% | -7.9% |
| ROICReturn on invested capital | +17.4% | +9.2% | +5.0% | -21.6% |
| ROCEReturn on capital employed | +9.8% | +9.7% | +6.1% | -14.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.97x | 0.77x | 1.24x | 0.94x |
| Net DebtTotal debt minus cash | -$298M | $54.0B | $85.1B | $889M |
| Cash & Equiv.Liquid assets | $4.2B | $24.4B | $8.5B | $17.9B |
| Total DebtShort + long-term debt | $4.0B | $78.4B | $93.6B | $18.8B |
| Interest CoverageEBIT ÷ Interest expense | 2.12x | 4.71x | 1.68x | -9.03x |
Total Returns (Dividends Reinvested)
CVS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,195 today (with dividends reinvested), compared to $7,307 for MOH. Over the past 12 months, CVS leads with a +24.2% total return vs MOH's -39.9%. The 3-year compound annual growth rate (CAGR) favors CVS at 7.8% vs MOH's -13.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.7% | +8.8% | +2.4% | +26.8% |
| 1-Year ReturnPast 12 months | -39.9% | -7.9% | +24.2% | -11.4% |
| 3-Year ReturnCumulative with dividends | -35.8% | -21.4% | +25.3% | -22.6% |
| 5-Year ReturnCumulative with dividends | -26.9% | -2.8% | +11.9% | -18.9% |
| 10-Year ReturnCumulative with dividends | +323.6% | +217.0% | -2.2% | +74.6% |
| CAGR (3Y)Annualised 3-year return | -13.8% | -7.7% | +7.8% | -8.2% |
Risk & Volatility
Evenly matched — MOH and CVS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 94.8% from its 52-week high vs MOH's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.04x | 0.59x | 0.05x | 0.39x |
| 52-Week HighHighest price in past year | $333.00 | $409.70 | $85.15 | $64.15 |
| 52-Week LowLowest price in past year | $121.06 | $234.60 | $58.35 | $25.08 |
| % of 52W HighCurrent price vs 52-week peak | +57.7% | +88.8% | +94.8% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 79.6 | 83.3 | 62.0 | 83.9 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 8.1M | 7.3M | 5.7M |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MOH as "Buy", UNH as "Buy", CVS as "Buy", CNC as "Buy". Consensus price targets imply 18.0% upside for CVS (target: $95) vs -13.6% for MOH (target: $166). For income investors, CVS offers the higher dividend yield at 3.31% vs UNH's 2.39%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.09 | $385.43 | $95.20 | $51.00 |
| # AnalystsCovering analysts | 38 | 52 | 41 | 43 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% | +3.3% | — |
| Dividend StreakConsecutive years of raises | — | 25 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $8.70 | $2.67 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +10.0% | +1.7% | 0.0% | +1.8% |
UNH leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNC leads in 1 (Valuation Metrics). 2 tied.
MOH vs UNH vs CVS vs CNC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MOH or UNH or CVS or CNC a better buy right now?
For growth investors, Centene Corporation (CNC) is the stronger pick with 19.
4% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (38. 3x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MOH or UNH or CVS or CNC?
On trailing P/E, Molina Healthcare, Inc.
(MOH) is the cheapest at 21. 5x versus CVS Health Corporation at 58. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 11. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MOH or UNH or CVS or CNC?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +11.
9%, compared to -26. 9% for Molina Healthcare, Inc. (MOH). Over 10 years, the gap is even starker: MOH returned +334. 0% versus CVS's -2. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MOH or UNH or CVS or CNC?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately -1702% more volatile than MOH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — MOH or UNH or CVS or CNC?
By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.
4% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, MOH leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MOH or UNH or CVS or CNC?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -3. 4% for Centene Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 9% for CNC. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MOH or UNH or CVS or CNC more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 11.
3x forward P/E versus 38. 3x for Molina Healthcare, Inc. — 27. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVS: 18. 0% to $95. 20.
08Which pays a better dividend — MOH or UNH or CVS or CNC?
In this comparison, CVS (3.
3% yield), UNH (2. 4% yield) pay a dividend. MOH, CNC do not pay a meaningful dividend and should not be held primarily for income.
09Is MOH or UNH or CVS or CNC better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 3% yield). Both have compounded well over 10 years (CVS: -2. 2%, CNC: +85. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MOH and UNH and CVS and CNC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MOH is a mid-cap quality compounder stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; CNC is a mid-cap high-growth stock. UNH, CVS pay a dividend while MOH, CNC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.